RxDoctor Payments Data

Michelle Lightfoot, MD

Obstetrics & Gynecology · Boston, MANPI 1699189910

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,795 of the $23,461 with a category attached, or 84.4%. GSK accounts for 91.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $11,154 and has fallen 62.0% since, to $4,237 in 2025. Among obstetrics & gynecology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,461in general payments, 2019–2025

Across 30 payments — averaging $782.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$21K
  • Merck$2K
  • Seagen Inc.$65
  • Medtronic$24
  • AbbVie$24
  • Hologic Sales And Service, LLC$21
$144,671in research payments, 2019–2025

Across 7 payments — averaging $20,667 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$145K

What the payments were for

  • Consulting fees$19,79584%
  • Travel & lodging$2,78812%
  • Food & beverage$8774%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK20$21,428
Merck6$1,898
Seagen Inc.1$65
Medtronic1$24
AbbVie1$24
Hologic Sales And Service, LLC1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,461 in reported general payments places this provider in the 95th percentile of 910 obstetrics & gynecology providers in Massachusetts.

See all obstetrics & gynecology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$35,512
Medicare patients
72
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →